ClinConnect ClinConnect Logo
Search / Trial NCT01146132

Nutrition and Physical Activity in Patients With Cerebrovascular Disease

Launched by MANON GANTENBEIN · Jun 16, 2010

Trial Information

Current as of October 15, 2025

Completed

Keywords

Nutrition Physical Activity Cerebrovascular Disease Wine Consumption Bmi Pulse Transit Time Transcranial Doppler Sonography

ClinConnect Summary

Quality of life in the elderly and their families is severely affected by stroke and cognitive dysfunction caused by atherosclerosis of the brain supplying arteries. Nutrition, namely a Mediterranean-style diet, nuts, soybean products, whole grain products, dark chocolate, fish oil and avoidance of salt, and regular physical activity play a major role in the prevention of these diseases. Data are available on cardiac patients, however little is known on cerebrovascular patients. The role of red wine in the protection of cerebrovascular disease is discussed; it may be simply an epiphenomenon...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • In- and outpatients of the Neurology Department of the CHL and their family members
  • Carotid atherosclerosis assessed by B-mode ultrasound of at least 20% lumen reduction
  • No acute stroke/TIA/amaurosis fugax (at least 3 months ago)
  • Temporal ultrasound window suitable for recording of the middle cerebral artery
  • Ability to give informed consent
  • Exclusion Criteria:
  • No signed informed consent
  • patient not able to give informed consent

About Manon Gantenbein

Manon Gantenbein is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on ethical practices and regulatory compliance, Gantenbein leads initiatives that encompass diverse therapeutic areas, ensuring rigorous methodologies and robust data collection. The organization's mission is to foster collaboration among stakeholders, including researchers, healthcare professionals, and patients, to facilitate the development of safe and effective treatments. Through a patient-centered approach, Manon Gantenbein aims to contribute significantly to the scientific community and enhance the quality of care in healthcare settings.

Locations

Luxembourg, Luxembourg

Patients applied

0 patients applied

Trial Officials

Dirk Droste, Pr, MD

Principal Investigator

Centre Hospitalier du Luxembourg

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials